Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SpherHA is a medical device developed by Tiss' You, specifically designed for intra-articular viscosupplementation in patients with osteoarthritis. The product consists of cross-linked hyaluronic acid (HA) processed into a spherical micro-particle (microsphere) morphology. This unique spherical structure is engineered to provide enhanced rheological properties, offering superior lubrication and mechanical shock absorption within the joint space compared to traditional linear HA formulations. By replenishing the viscoelasticity of the synovial fluid, SpherHA helps to reduce friction between articular surfaces, thereby alleviating pain and improving joint mobility. It is typically administered via intra-articular injection and is intended to provide a long-lasting therapeutic effect due to the stability of the cross-linked microspheres.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SpherHA.